ENTITY

Neurocrine Biosciences (NBIX US)

37
Analysis
Health Care • United States
Neurocrine Biosciences, Inc. is focused on the discovery and development of therapeutics for neuropsychiatric, neuroinflammatory, and neurodegenerative diseases and disorders. The Company is developing therapeutic interventions for anxiety, depression, Alzheimer's disease, insomnia, stroke, malignant brain tumors, multiple sclerosis, obesity, and diabetes.
more
Exchange Announcement • 01 Aug 2026 04:10

S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Exchange Announcement • 01 Aug 2026 04:05

Current Report (Amendment) (Form 8-K/A | Period ending 2026-05-14)

Exchange Announcement • 31 Jul 2026 08:00

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 31 Jul 2026 04:02

Current Report (Form 8-K | Period ending 2026-07-30)

Exchange Announcement • 29 May 2026 04:01

Current Report (Form 8-K | Period ending 2026-05-27)

x